4Tomaras AP, Dorsey CW, Edelmann RE, et al. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii : involvement of a novel chaperone-usher pill assembly system[J]. Microbiology, 2003,149(Pt 12) : 3473-- 84.
5Stepanovic S,Vukovic D,Dakic I,et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation[J]. J Microbiol Methods, 2000,40(2) - 175-- 9.
6Stepanovic S,Cirkovic I,Ranin L,et al. Biofilm formation by Salmonella spp and Listeria monocytogenes on plastic surface [J]. Lett Appl Microbiol,2004,38(5):428-32.
7Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing : fifteenth informational supplement [S].2007. M100--S16.
8Rodriguez-Bano J, Marti S, Soto S, et al. Biofilm format/on in Acinetobacter baumannii:assoeiated features and clinical implications[J]. Clin Microbiol Infect, 2008,14 (3) : 276-- 8.
9Brown S, Young HK, Amyes SG. Characterisation of OXA- 51, a novel class D carbapenemase found in genetically unrelated clinical strains ofAcinetobacterbaumannii[J]. Clin Mi crobiol Infect, 2005,11 ( 1 ) : 15-23.
10Rodriguez-Bano J, Martis S, Soto S, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications[J]. Clin Microbiol Infect,2008,14(3):276-278.
